Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 15 | 2019 | 458 | 2.300 |
Why?
|
| Breast Neoplasms | 31 | 2023 | 3110 | 2.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 11 | 2024 | 461 | 1.330 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2025 | 3476 | 0.860 |
Why?
|
| Artificial Intelligence | 7 | 2025 | 391 | 0.710 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2025 | 626 | 0.660 |
Why?
|
| Radiographic Image Enhancement | 6 | 2019 | 449 | 0.620 |
Why?
|
| Diagnosis, Computer-Assisted | 6 | 2025 | 337 | 0.600 |
Why?
|
| ROC Curve | 15 | 2023 | 775 | 0.590 |
Why?
|
| Algorithms | 14 | 2025 | 1953 | 0.580 |
Why?
|
| Risk Assessment | 6 | 2019 | 2440 | 0.550 |
Why?
|
| Image Enhancement | 8 | 2018 | 505 | 0.440 |
Why?
|
| Genomics | 2 | 2019 | 848 | 0.410 |
Why?
|
| Machine Learning | 5 | 2025 | 341 | 0.400 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1448 | 0.390 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2025 | 1261 | 0.380 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 184 | 0.380 |
Why?
|
| Pattern Recognition, Automated | 7 | 2013 | 217 | 0.350 |
Why?
|
| Retrospective Studies | 13 | 2025 | 10164 | 0.310 |
Why?
|
| Female | 36 | 2025 | 48698 | 0.310 |
Why?
|
| Breast | 6 | 2018 | 294 | 0.300 |
Why?
|
| Diagnostic Imaging | 4 | 2025 | 452 | 0.280 |
Why?
|
| Middle Aged | 19 | 2025 | 27569 | 0.250 |
Why?
|
| Genes, BRCA2 | 3 | 2014 | 162 | 0.250 |
Why?
|
| Adult | 18 | 2025 | 27918 | 0.240 |
Why?
|
| Humans | 39 | 2025 | 93511 | 0.230 |
Why?
|
| Health Information Interoperability | 1 | 2025 | 7 | 0.230 |
Why?
|
| Data Curation | 1 | 2025 | 10 | 0.230 |
Why?
|
| Adnexal Diseases | 1 | 2025 | 22 | 0.220 |
Why?
|
| Aged | 15 | 2025 | 20430 | 0.220 |
Why?
|
| Thyroid Nodule | 1 | 2025 | 60 | 0.210 |
Why?
|
| Pilot Projects | 5 | 2025 | 917 | 0.210 |
Why?
|
| Genes, BRCA1 | 3 | 2014 | 191 | 0.210 |
Why?
|
| Hydronephrosis | 1 | 2023 | 30 | 0.200 |
Why?
|
| Breast Density | 3 | 2019 | 37 | 0.200 |
Why?
|
| Phenotype | 5 | 2019 | 2544 | 0.200 |
Why?
|
| Radiologists | 1 | 2024 | 53 | 0.200 |
Why?
|
| Software | 5 | 2023 | 670 | 0.190 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 7061 | 0.180 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2025 | 259 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2025 | 367 | 0.180 |
Why?
|
| Radiography, Thoracic | 1 | 2024 | 327 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2019 | 2465 | 0.170 |
Why?
|
| Tumor Burden | 2 | 2019 | 321 | 0.160 |
Why?
|
| BRCA2 Protein | 3 | 2008 | 173 | 0.160 |
Why?
|
| Contrast Media | 7 | 2019 | 988 | 0.160 |
Why?
|
| Parenchymal Tissue | 1 | 2019 | 7 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2014 | 1006 | 0.150 |
Why?
|
| Mutation | 5 | 2015 | 4272 | 0.140 |
Why?
|
| Area Under Curve | 4 | 2013 | 335 | 0.130 |
Why?
|
| Sensitivity and Specificity | 7 | 2024 | 1922 | 0.130 |
Why?
|
| Bayes Theorem | 3 | 2013 | 402 | 0.120 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 300 | 0.120 |
Why?
|
| BRCA1 Protein | 2 | 2008 | 214 | 0.110 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 84 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 26 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 165 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2014 | 123 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1518 | 0.100 |
Why?
|
| Subtraction Technique | 2 | 2011 | 125 | 0.100 |
Why?
|
| Multigene Family | 1 | 2014 | 203 | 0.100 |
Why?
|
| Age Factors | 2 | 2008 | 1906 | 0.100 |
Why?
|
| Risk Management | 1 | 2012 | 38 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 1 | 2012 | 242 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2025 | 702 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 217 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 206 | 0.090 |
Why?
|
| Gene Expression | 1 | 2016 | 1301 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2015 | 548 | 0.090 |
Why?
|
| Gene Frequency | 1 | 2014 | 700 | 0.090 |
Why?
|
| Reproducibility of Results | 7 | 2013 | 2715 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1713 | 0.090 |
Why?
|
| Young Adult | 3 | 2025 | 6930 | 0.090 |
Why?
|
| Discriminant Analysis | 2 | 2010 | 64 | 0.080 |
Why?
|
| Genome, Human | 1 | 2015 | 823 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 1139 | 0.080 |
Why?
|
| Genotype | 1 | 2014 | 1866 | 0.070 |
Why?
|
| Incidence | 1 | 2012 | 1701 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1660 | 0.070 |
Why?
|
| Fractals | 1 | 2007 | 41 | 0.060 |
Why?
|
| Observer Variation | 2 | 2024 | 570 | 0.060 |
Why?
|
| Radiology | 1 | 2008 | 192 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2484 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 109 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2004 | 129 | 0.050 |
Why?
|
| Risk | 1 | 2004 | 657 | 0.050 |
Why?
|
| Bone Density | 1 | 2004 | 237 | 0.050 |
Why?
|
| Reference Standards | 1 | 2023 | 146 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2025 | 4560 | 0.050 |
Why?
|
| Biopsy | 2 | 2017 | 1175 | 0.040 |
Why?
|
| Risk Factors | 2 | 2014 | 5898 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 2001 | 29 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2024 | 283 | 0.040 |
Why?
|
| Benzoates | 1 | 2001 | 33 | 0.040 |
Why?
|
| Automation | 2 | 2014 | 105 | 0.040 |
Why?
|
| Pollen | 1 | 2001 | 84 | 0.040 |
Why?
|
| Fuzzy Logic | 2 | 2010 | 16 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2001 | 373 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2010 | 391 | 0.030 |
Why?
|
| Male | 3 | 2025 | 44553 | 0.030 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 88 | 0.030 |
Why?
|
| Water | 2 | 2014 | 307 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1366 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 2017 | 51 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 113 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 873 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1170 | 0.030 |
Why?
|
| Prognosis | 2 | 2015 | 3910 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 1546 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2008 | 585 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 482 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 81 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2585 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 572 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 790 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 382 | 0.020 |
Why?
|
| Probability | 1 | 2014 | 355 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 1721 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 278 | 0.020 |
Why?
|
| Child | 1 | 2023 | 7355 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 189 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1117 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 9606 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 580 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 302 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2017 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 356 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 233 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2011 | 402 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 68 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 416 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 1210 | 0.020 |
Why?
|
| Calcaneus | 1 | 2004 | 41 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 608 | 0.010 |
Why?
|
| Mass Screening | 1 | 2007 | 696 | 0.010 |
Why?
|
| Mineral Oil | 1 | 2001 | 1 | 0.010 |
Why?
|
| Papaver | 1 | 2001 | 2 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2001 | 9 | 0.010 |
Why?
|
| Plants, Medicinal | 1 | 2001 | 39 | 0.010 |
Why?
|
| Viscosity | 1 | 2001 | 51 | 0.010 |
Why?
|
| Zea mays | 1 | 2001 | 27 | 0.010 |
Why?
|
| Microspheres | 1 | 2001 | 88 | 0.010 |
Why?
|
| Seeds | 1 | 2001 | 62 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 282 | 0.010 |
Why?
|
| Polymers | 1 | 2001 | 218 | 0.010 |
Why?
|